Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Prepaid Assets (2020 - 2025)

Cardiol Therapeutics filings provide 3 years of Prepaid Assets readings, the most recent being $1.1 million for Q4 2022.

  • On a quarterly basis, Prepaid Assets fell 51.25% to $1.1 million in Q4 2022 year-over-year; TTM through Dec 2022 was $1.1 million, a 51.25% decrease, with the full-year FY2022 number at $1.1 million, down 51.25% from a year prior.
  • Prepaid Assets hit $1.1 million in Q4 2022 for Cardiol Therapeutics, down from $2.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.2 million in Q4 2021 to a low of $266787.7 in Q4 2020.
  • Median Prepaid Assets over the past 3 years was $1.1 million (2022), compared with a mean of $1.2 million.
  • Biggest five-year swings in Prepaid Assets: surged 742.79% in 2021 and later tumbled 51.25% in 2022.
  • Cardiol Therapeutics' Prepaid Assets stood at $266787.7 in 2020, then surged by 742.79% to $2.2 million in 2021, then tumbled by 51.25% to $1.1 million in 2022.
  • The last three reported values for Prepaid Assets were $1.1 million (Q4 2022), $2.2 million (Q4 2021), and $266787.7 (Q4 2020) per Business Quant data.